Breaking News

UiPath has exceeded expectations in Q4 of 2024, achieving record sales and marking its first profitable quarter since going public....

MicroStrategy has unveiled a new proposal for a private offering of $500 million in convertible senior notes due in 2031....

On March 13, 2024, Ocean Power Technologies revealed a third quarter EPS of $(0.11), consistent with the previous year. ====================...

FTC Solar announced its Q4 financial results on March 13, 2024, revealing a mixed performance. The company reported a quarterly...

Quoin Pharmaceuticals' Q4 Earnings Report Unveiled On March 13, 2024, Quoin Pharmaceuticals (NASDAQ: QNRX) disclosed its Q4 earnings, shedding light...

Spruce Biosciences announced an EPS of $(1.24) for FY23, marking an improvement from $(1.96) compared to the previous year. Collaboration...

Vroom Inc. released its Q4 financial results on March 13, 2024, impacting its stock performance significantly. Here is a breakdown...

Cue Health (NASDAQ: HLTH) released its Q4 earnings on March 13, 2024, revealing some key highlights: - Earnings: Cue Health...

On March 13, 2024, Poseida Therapeutics received Orphan Drug Designation from the FDA for their innovative treatment, P-BCMA-ALLO1, targeting Multiple...

Needham analyst Serge Belanger has reiterated his Buy rating and $28 price target for Liquidia (NASDAQ:LQDA) on March 13, 2024....